Hypertension in children
175 results
1 - 100
Pharmacological interventions for hypertension in children
Hypertension in children 
USPSTF: Insufficient evidence to screen children and adolescents for hypertension- Useful history, physical, and laboratory findings for predicting secondary hypertension in children and adolescents
- USPSTF finds evidence insufficient to recommend hypertension screening in children (I statement)
- Over 13.6 years, children with hypertension are twice as likely to have major adverse cardiovascular events
- Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
- Fewer than 4% of children with newly diagnosed hypertension in primary care or school settings have secondary causes
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Interpretation of urine test results in children
- Calcium channel blockers for people with chronic kidney disease requiring dialysis
- Heart auscultation and blood pressure recording in children
- Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women
- Overweight and obesity in children
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Epistaxis
- Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Most children born prematurely survive to early- to mid-adulthood without major comorbidities
- Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Polycystic kidney disease
- Interventions for preventing and managing advanced liver disease in cystic fibrosis
- Headache in children
- Impaired vision
- Interventions for idiopathic steroid‐resistant nephrotic syndrome in children
- Eye symptoms and signs of systemic diseases
- Pharmacotherapy for hyperuricaemia in hypertensive patients
- Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Guanylate cyclase stimulators for pulmonary hypertension
- UTI: low rates of renal scarring in children; not associated with development of HTN, CKD, or ESRF by age 10
- Minimal, if any, association between labor epidural analgesia and the risk of autism spectrum disorder in children
- Maternal and neonatal risks and benefits associated with bariatric surgery
- Modes of administration of antibiotics for symptomatic severe urinary tract infections
- Down's syndrome
- Protein restriction for children with chronic kidney disease
- New diagnostic criteria for pseudotumor cerebri
- Renal disease in children (nephrotic and nephritic syndrome)
- Advice to reduce dietary salt for prevention of cardiovascular disease: Cochrane systematic review
- Low‐sodium salt substitutes and blood pressure
- Raynaud's phenomenon (RP) or white finger disease
- Phosphodiesterase 5 inhibitors for pulmonary hypertension: Cochrane systematic review
- One-third of people eligible for weight loss drugs are not represented in clinical research
- Darbepoetin for the anaemia of chronic kidney disease
- Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
- Growth hormone for children with chronic kidney disease: Cochrane systematic review
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
- Psoriasis
- Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
- Effect of adrenergic agonist oral decongestants on blood pressure
- Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults: Cochrane systematic review
- Interventions for idiopathic steroid-resistant nephrotic syndrome in children
- Foot orthoses for treating paediatric flat feet